{"name":"Daniel George, MD","slug":"daniel-george-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQS3pVUGFVYnQ1YTBWOWxYbE8zbmxHRXFWM0NTWEhwUm9iQ0UxdkNsbnlyYmJwUkFXckFfOWYtUWFlZERZOHY5ZnZfN1JiWUFLbGpyTV80UnZXem5ZSjNxb1p1ZHRHdy1sbk50OUN6N3MyVHlEVkVpYlMyWXN3TVdLNDBHSThJaVUxcHRFbzhaTTlHVkpI?oc=5","date":"2025-11-02","type":"pipeline","source":"The Washington Post","summary":"Top drug regulator resigns, sued after post criticizing a treatment - The Washington Post","headline":"Top drug regulator resigns, sued after post criticizing a treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQdGlBa2hrVFk4TzVqU1lUQ010aHNVanV0Wk5fZjdmNEJKakxsMmhWaU5JYi1aQzVRZjFING1sUGF4eC02SlE2U0d5N2l0UVVHcWFaTDBsaHpScTNjRXhjeHctUXJZZ0QzVkVacDI3LVdNOE5sSktrd1BNTDhTTXQ1Wm5HdE5PVV82dnZyU0VOZEFDeHV6YWd1ZXZ5emdRTkRYU0l1Qms1dW1VZ2FyN2ZjaQ?oc=5","date":"2025-09-10","type":"trial","source":"Urology Times","summary":"Study to assess combination of MRI and PSMA-PET for prostate cancer detection - Urology Times","headline":"Study to assess combination of MRI and PSMA-PET for prostate cancer detection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNT1JFR29sNkNiOWktOXNGa1FSVDRFTkJhY1FHRzZndk5GT2VJdEthbUR4QzJwRVhkeS1sNURCN1FTOHBXS1U5MHhNWElQU2NlTVZpbUZkRERwOU9UcW50TUlWTjlBQUdDUjNJQTdkUTc2NWZRYnpiYldjaWJzdUF3ekh6WmZMbFlOX3pJZEZuSTQ3WXJ5dTVxc25UWVNnS2ZNZ3Z2UjhDcmNXVmtPTXpObTNvLS00ZEhxSEE?oc=5","date":"2025-08-29","type":"regulatory","source":"Urology Times","summary":"FDA approves 3-month formulation of leuprolide mesylate for advanced prostate cancer - Urology Times","headline":"FDA approves 3-month formulation of leuprolide mesylate for advanced prostate cancer","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQTENSN1EyZmE4Zmh6Ni16b0gwYURrOTczM0ljZlhPS1RlR0FOWjNHcVg1MTlKV1FTdVF6aFFIcUtadzByWlk5bGZJVlpBakxId2FSaDVLRnJKa2tNSEFsMERBY1NPYjJubzJreDB5NFNFT0U3VTVqSVNJZ2twcGhXbGIwZW9tWVpEcWFvd2s2cG5CWkFfNGpwV0lBREJfelhN?oc=5","date":"2025-05-30","type":"pipeline","source":"Urology Times","summary":"ORIC-944 shows promise in combination with AR inhibitors in mCRPC - Urology Times","headline":"ORIC-944 shows promise in combination with AR inhibitors in mCRPC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOWEI3NmRIOUttU041bmNyWmJfZkFneW9HMTRGbDN4OTRkdk1RemNyWXliLVNEUkxLY2FKTktUY1hacXpXZ2ZVMzV6amdVSTRweHhibUJad3JBVFNRdG9ma2NRd3QwQ0xpM3hYSndsM2JyM09SMzRGQjVSekZaTnFsY19kQXRRVGRfX2xVanl4NmRHeVp4cS1tajNBNFI4Y2Nna2tTUncxNzJuNmxsUV9oZmJqZGhNb1k2aW1r?oc=5","date":"2024-12-12","type":"regulatory","source":"ASCO Daily News","summary":"Challenges Remain in RCC Treatment Beyond Contemporary First-Line IO Therapy: Are Second-Line Non-IO Regimens the Answer? - ASCO Daily News","headline":"Challenges Remain in RCC Treatment Beyond Contemporary First-Line IO Therapy: Are Second-Line Non-IO Regimens the Answer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxONFN4OTJKQWhWYmZ5ZmpqRlJ4Z2NIZy1iblh4UlRGeG5OTENoNFpEVmhKcUJHajVZYVFwZWJWaUM1bHp3Q1hMaTI5WDBETk5UNVJxM1o3UE5GdGRSZE55MG16amxobXl0QUY5YTdQMlZfWGx4ZFh1dXZMXzQ2TGlkZTV1bmFHMldHSGYyQXVkU3lWWV9MTWE5TC0xWU1JSER0V2J0M185OFlTZFBWbUVSZzROYmxRVWpvTWNydlBwMm9nR3BwQnhCVnlKMW9wYUF6bXRVVzV3Z2JDRnFfU3owREhwZlgyNnlEOXo2d1h5d2R0V3RPbFhuLTV2bnFTeDA?oc=5","date":"2023-06-15","type":"trial","source":"UroToday","summary":"Exploring Racial Biases in Clinical Trials: The PANTHER Study's Findings on Prostate Cancer - Dan George - UroToday","headline":"Exploring Racial Biases in Clinical Trials: The PANTHER Study's Findings on Prostate Cancer - Dan George","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOYjhGQ1I3azN6TzdrZnB5czJFRFJwd3ZNSUItNTZKaG5Gb1hFX3JKRTNGeEhkbTBfaDhQa2xJNXFJbThWaUtiNEFFRWhKSTFnTXJhVjZPSk9QOEZXZ2ZlM0Q2ejBCWmZBSmJKb0ZjS2owVWJUY3pJLTgxcnczWEg3RWUwSEpkZlZpelNUNUIxSnAzcnlYM19iVHpHaFc2aDBIb19rVHVn?oc=5","date":"2023-05-31","type":"pipeline","source":"Duke Health","summary":"Black Men with Metastatic Prostate Cancer May Benefit From Drug Combination - Duke Health","headline":"Black Men with Metastatic Prostate Cancer May Benefit From Drug Combination","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxONks2XzJqZHdxdVlsc3Q3R1RBa29WR1VpSjJnZm10RDJyb1pUd0NlckpPeklscWdlcVFQWnFEcGJyTXpDbG11eFVkczJmbzBaYmpzVFYzYTlvQlFnY0wzSUNxRXRCRTNTU1E4cGREakRaM2s3czRIVUp4VGZiQ0pEVzZVMW4?oc=5","date":"2023-04-24","type":"pipeline","source":"Fierce Pharma","summary":"After massive equity awards, Regeneron's top 2 execs collected smaller pay packages in 2022 - Fierce Pharma","headline":"After massive equity awards, Regeneron's top 2 execs collected smaller pay packages in 2022","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPc3phZm1XZnp3NkdldTFOQzhmbU11ZUljYUFqMGhRbHJJNDV3a29GeHdXa1dOQVNqN3laNklESHltUVlpOTRfc0YyTy1adVpwRzZVVmQ0NzJ3b1BWOWdsdThVQVJUaWY3aUdzeUQ5UTJOTHR3ZWVILVphMWFabTRqeG1fRnBQZ21qWE4wQUh4LWFBZTdFSktKUnNB?oc=5","date":"2021-06-14","type":"pipeline","source":"Fierce Biotech","summary":"The top 10 highest paid biopharma R&D executives in 2020 - Fierce Biotech","headline":"The top 10 highest paid biopharma R&D executives in 2020","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5HaTJCd2VpRC1nR2R4Y3k2UDRzUENKdXg3Zkc1Z29WNE1Jd0xRVGZZMTNJaFJ4ckJYU3EzYVQ2eHE1N3J5dDdiX0t4QXJmbndQbV8yamlTUFlKZF9NZW11Zlhxa3lXMEJ6Nm9NazRrM081cFhBSmg4QjFmUQ?oc=5","date":"2020-08-05","type":"trial","source":"Wiley","summary":"A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer - Wiley","headline":"A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant m","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE5SR1ZoT2xPNkFZTU1wOXRaY2VwX0tkNnJlalZ1Rl9ZLS1ON1VkV21BN00ydmwzOTNkdDRBckt5THVmcnh1ZG9veWVBcW1WYlhqNTRxQ09wbXljQUYzLWEzcg?oc=5","date":"2020-05-29","type":"pipeline","source":"NEJM","summary":"Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer - NEJM","headline":"Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNWlVGUk45b0t1cWdnVlZhZTVHaE5ySHlKX0tnSEtmM0U4ZEFkdU1Rdjc0dUdXUnFBdHk0VVN3X1ppZmd0bHdvUy1SaHlQbmpHMms2NDB0ZWk1MnlYQmh1dDE2bDdRc2NWU2pMLUJZUm9RbUZFLVd0WUlyMlA5R09rMVZ4V3d3NGtWR2lPa0hpN21UM1NOOWRMdUEwUUdqd18yUjh3OFJrU3k?oc=5","date":"2020-01-08","type":"pipeline","source":"statnews.com","summary":"A new biotechnology and pharmaceutical industry commitment to patients and the public - statnews.com","headline":"A new biotechnology and pharmaceutical industry commitment to patients and the public","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}